Medial Enhancement Technique for the Treatment of Old Femoral Neck Fractures

Exclusion Criteria

• •1. Participants who have not reached the primary endpoint of other drug, biological agent, or medical device clinical trials prior to enrollment;
• •2. Known history of hypersensitivity to one or more implanted materials by the patient;
• •3. Judged by the investigator as physically frail or unable to tolerate surgery due to other systemic diseases;
• •4. Active infectious foci in the hip joint or other parts of the body, as judged by the investigator;
• •5. Diagnosed with metabolic bone disease, radiation-induced bone disease, etc.;
• •6. Severe hip contracture deformity or severe muscle weakness that has been immobilized in functional position for a long time and painless;
• •7. Suffering from inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.;
• •8. Patients who lack the mental capacity or understanding to meet the requirements of participating in the study, or are difficult to cooperate with;
• •9. Other situations where the investigator deems the participant unsuitable for inclusion.